Lee, M.-J.; Fallen, S.; Zhou, Y.; Baxter, D.; Scherler, K.; Kuo, M.-F.; Wang, K.
The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA. J. Clin. Med. 2019, 8, 1648.
https://doi.org/10.3390/jcm8101648
AMA Style
Lee M-J, Fallen S, Zhou Y, Baxter D, Scherler K, Kuo M-F, Wang K.
The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA. Journal of Clinical Medicine. 2019; 8(10):1648.
https://doi.org/10.3390/jcm8101648
Chicago/Turabian Style
Lee, Ming-Jen, Shannon Fallen, Yong Zhou, David Baxter, Kelsey Scherler, Meng-Fai Kuo, and Kai Wang.
2019. "The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA" Journal of Clinical Medicine 8, no. 10: 1648.
https://doi.org/10.3390/jcm8101648
APA Style
Lee, M. -J., Fallen, S., Zhou, Y., Baxter, D., Scherler, K., Kuo, M. -F., & Wang, K.
(2019). The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA. Journal of Clinical Medicine, 8(10), 1648.
https://doi.org/10.3390/jcm8101648